Market Research Logo

Global Biologic Therapeutics Market 2015-2019

About biologic therapeutics

Biologic therapeutics include virus, therapeutic serums, toxins, allergenic products, antitoxin, blood components or derivatives, vaccines, blood, and proteins (except any chemically synthesized polypeptide). They also include analogous products, arsphenamine, or derivatives of arsphenamine (or any other trivalent organic arsenic compound) for the prevention, treatment, or cure of a disease. The differences between the biologics and small molecules include the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics have a higher molecular weight and a complex molecular structure. They are usually derived from living entities, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures (thermolabile) and light.

Technavio's analysts forecast the global biologic therapeutics market to grow at a CAGR of 8.26% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global biologic therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales protein therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics).

Other protein therapeutics covers proteins such as cytokines, fusion proteins, peptide antibiotics, peptide hormones, and blood factors.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.

Technavio's report, Global Biologic Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global biologic therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA
Key vendors
  • Amgen
  • F. Hoffmann-La Roche
  • Novo Nordisk
  • Sanofi
Other prominent vendors
  • AbbVie
  • AstraZeneca
  • Bavarian Nordic
  • Baxter International
  • Beijing Minhai Biotechnology
  • Bharat Biotech
  • Bharat Immunologicals and Biologicals
  • Bio Med Pvt.
  • bioCSL
  • Biodel
  • Bristol-Myers Squibb
  • Diamyd Medical
  • DiaVacs
  • Dynavax Technologies
  • Eli Lilly
  • Generex Biotechnology
  • Hualan Biological Engineering
  • Imunoloski Zavod
  • Indian Immunologicals
  • Janssen
  • JN International Medical
  • Kaketsuken
  • LG Life Sciences
  • Macrogenics
  • MannKind
  • Merck
  • Mitsubishi Tanabe Pharma
  • Nuron Biotech
  • Osiris Therapeutics
  • Pfizer
  • Protalix
  • Protein Sciences
  • Serum Institute of India
  • Shenzhen Kangtai Biological Products
  • Sinovac Biotech
  • Tolerion
  • Vacunas Finlay
  • XOMA
  • Zydus Cadila
Market driver
  • Reimbursement support for biologics
  • For a full, detailed list, view our report
Market challenge
  • High cost of therapy
  • For a full, detailed list, view our report
Market trend
  • Emergence of targeted and combination therapies
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Biologic Therapeutics Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Biologic Therapeutics Market:

Other Prominent Vendors in the market are: Amgen, F. Hoffmann-La Roche, Novo Nordisk, and Sanofi.

Commenting on the report, an analyst from Technavio’s team said: “R&D in the market is rising in terms of the increasing collaborations between companies and the increase in mergers and acquisitions. For instance, in January 2014, Sanofi and Alnylam signed an agreement for the development of treatment therapies for rare genetic diseases.”

According to the report, Biologic therapeutics are expensive and cannot be afforded by all, but the reimbursement of diagnostic kits and biologic drugs is expected to drive the market during the forecast period.

Further, the report states that competition is a major challenge for the market and varies depending on the disease. However, the market competition is negligible for biologics such as Fabrazyme, which is the only approved therapy in the US for the treatment of Fabry disease.

Companies Mentioned

Amgen, F. Hoffmann-La Roche, Novo Nordisk, Sanofi.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global biologic therapeutics market 2014-2019 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by type of molecules
    • Table Global biologic therapeutics market segmentation by type of molecules
    • Table Global biologic therapeutics market segmentation by type of molecules 2014
    • Table Global biologic therapeutics market segmentation by type of molecules 2014-2019 ($ billions)
  • Global protein therapeutics market
    • Introduction
    • Drivers, challenges, and trends
      • Table Key drivers and challenges of global protein therapeutics market
      • Table Key trends of global protein therapeutics market
      • Table Global protein therapeutics market 2014-2019 ($ billions)
    • Market segmentation by type of molecules
      • Table Global protein therapeutics market 2014
      • Table Global protein therapeutics market by type of molecules 2014-2019 ($ billions)
      • Table Global monoclonal antibodies market 2014-2019 ($ billions)
      • Table Global enzymes market 2014-2019 ($ billions)
      • Table Global other protein therapeutics market 2014-2019 ($ billions)
  • Global vaccines market
    • Introduction
    • Drivers, challenges, and trends
      • Table Drivers of global vaccines market
      • Table Challenges of global vaccines market
      • Table Trends in global vaccines market
      • Table Global vaccines market 2014-2019 ($ billions)
    • Market segmentation by end-user age group
      • Table Global vaccines market by end-user age group 2014
      • Table Global vaccines market by end-user age group 2014-2019 ($ billions)
      • Table Global pediatric vaccines market 2014-2019 ($ billions)
      • Table Global adult vaccines market 2014-2019 ($ billions)
  • Global cell therapy market
    • Introduction
    • Drivers, challenges, and trends
      • Table Key factors influencing the global cell therapy market
    • Market size and forecast
      • Table Global cell therapy market 2014-2019 ($ billions)
  • Geographical segmentation
    • Table Global biologic therapeutics market by geography 2014
    • Biologic therapeutics market in Americas
      • Table Biologic therapeutics market in Americas 2014-2019 ($ billions)
    • Biologic therapeutics market in EMEA
      • Table Biologic therapeutics market in EMEA 2014-2019 ($ billions)
    • Biologic therapeutics market in APAC
      • Table Biologic therapeutics market in APAC 2014-2019 ($ billions)
      • Table Global biologic therapeutics market by geography 2014-2019 ($ billions)
  • Market drivers
    • Reimbursement support for biologics
    • Promising drug pipeline
    • Focus on development of novel mechanisms
    • Increase in industry-academia collaborations
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost of therapy
    • Stringent regulatory guidelines
    • Fierce market competition
    • Cold chain management
    • Poor diagnosis and screening
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Emergence of targeted and combination therapies
    • Increase in R&D
    • Shift in focus to untapped markets
    • Rise in public awareness
  • Vendor landscape
    • Competitive scenario
    • Key news
    • Mergers and acquisitions
    • Market share analysis
      • Amgen
        • Table Revenue of Enbrel 2012-2014 ($ millions)
        • Table Revenue of Epogen 2012-2014 ($ millions)
        • Table Revenue of Neulasta/Neupogen 2012-2014 ($ millions)
        • Table Revenue of vectibix 2012-2014 ($ millions)
        • Table Revenue of Xgeva 2012-2014 ($ millions)
        • Table Revenue of Prolia 2012-2014 ($ millions)
    • F. Hoffmann-La Roche
      • Table Revenue of Avastin 2012-2014 ($ millions)
      • Table Revenue of Kadcyla 2013 and 2014 ($ millions)
      • Table Revenue of Lucentis 2012-2014 ($ millions)
      • Table Revenue of Rituxan/MabThera 2012-2014 ($ millions)
      • Table Revenue of Pegasys 2012-2014 ($ millions)
      • Table Revenue of Perjeta 2013 and 2014 ($ millions)
      • Table Revenue of Pulmozyme 2012-2014 ($ millions)
    • Novo Nordisk
    • Sanofi
      • Table Revenue of Apridra 2012-2014 ($ millions)
      • Table Revenue of Cerezyme 2012-2014 ($ millions)
      • Table Revenue of Fabrazyme 2012-2014 ($ millions)
      • Table Revenue of Myozyme/Lumizyme 2012-2014 ($ millions)
      • Table Revenue of Lantus 2012-2014 ($ millions)
      • Table Revenue of Zaltrap 2012-2014 ($ millions)
    • Other and future prominent vendors
  • Key vendor analysis
    • Amgen
      • Table Amgen: Business segmentation by revenue 2014
      • Table Amgen: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Amgen: Geographical segmentation by revenue 2014
    • F. Hoffmann-La Roche
    • Novo Nordisk
      • Table Novo Nordisk: Business segmentation by revenue 2014
      • Table Novo Nordisk: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Novo Nordisk: Geographical segmentation by revenue 2014
      • Table Novo Nordisk: R&D expenditure 2014
    • Sanofi
      • Table Business segmentation by revenue 2013 and 2014 ($ billions)
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report